Jodi Devlin
Net worth: 139 133 $ as of 2026-07-30
Net worth: 139 133 $ as of 2026-07-30
Jodi Devlin is currently Chairman at FITABEO THERAPEUTICS LIMITED since 2022 and Chief Clinical Operations Officer at TriSalus Life Sciences, Inc. starting in 2023.
Former roles include Chief Executive Officer at AltaThera Pharmaceuticals LLC from 2018 to 2022 and President at Genelux Corp.
Education includes an MBA from the University of Washington and an undergraduate degree from the University of Oklahoma.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-19 | 30,646 ( 0.05% ) | 139 133 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Corporate Officer/Principal | 2023-09-04 |
FITABEO THERAPEUTICS LIMITED
FITABEO THERAPEUTICS LIMITED Pharmaceuticals: MajorHealth Technology Develops and markets medicines | Chairman | 2022-08-31 |
| Companies | Position | End |
|---|---|---|
AltaThera Pharmaceuticals LLC
AltaThera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Chief Executive Officer | 2022-11-30 |
| GENELUX CORPORATION | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
AltaThera Pharmaceuticals LLC
AltaThera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oklahoma
University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FITABEO THERAPEUTICS LIMITED
FITABEO THERAPEUTICS LIMITED Pharmaceuticals: MajorHealth Technology Develops and markets medicines | Health Technology |
TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions